Marketwatch Zydus Cadila gets tentative USFDA nod to market anti-cancer drug Admin September 24, 2020 Drug firm Zydus Cadila on Thursday said it has received tentative approval from the US health regulator to market anti-cancer drug Palbociclib Capsules. – Stocks-Markets-Economic Times Share on Facebook Tweet it Pin it Share it Email
